|
HS Code |
638465 |
As an accredited 3-Bromo-6-Methoxypyridazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-6-Methoxypyridazine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
3-Bromo-6-Methoxypyridazine sits among the handful of specialty intermediates that have changed how chemists design and modify molecules in recent years. Walking into a synthesis lab, you're likely to find this compound on the shelves of experienced researchers who often work on fine-tuning pharmaceuticals and agrochemical agents. Its formula—dictated by a classic pyridazine ring with a bromo atom holding down one corner and a methoxy group staking out another—brings a lot more than just complexity. Small molecules like this one open lots of possibilities for creating new synthetic routes, sometimes streamlining reactions and saving time and resources.
What first catches my attention about 3-Bromo-6-Methoxypyridazine is its manageable structure. The bromo substitution brings reactivity that chemists can count on for further substitution, coupling, or transformation reactions, while the methoxy group helps steer reactivity, affecting electronic properties in thoughtful ways. The purity often reaches north of 97%, so side tracks in your synthesis rarely sneak in because of impurities—this sort of reliability has always inspired confidence in experimental work.
On paper, the compound's IUPAC name almost reads like code, but to someone used to exploring pyridazine scaffolds, it spells opportunity. Imagine drawing out molecules on a whiteboard, sketching tweaks for better biological activity or improved crop protection. The bromine atom works like a flag for site-selective reactions, making it a great candidate for Suzuki–Miyaura and Buchwald–Hartwig couplings. I remember the first time I tried swapping bromo-aromatics for other functional groups; the excitement came from watching new compounds come together, often with improved yields compared to trickier chlorinated analogues.
The methoxy group does more than add mass. Its electron-donating nature can help direct subsequent transformations, sometimes increasing yields in palladium-catalyzed reactions, or adjusting basicity just enough to tune downstream steps. Even a small change on the ring alters reactivity, so keeping an eye on these details pays off. It's not about adding complexity for complexity's sake, but about achieving goals quicker, whether that means improving a drug lead or tweaking a dye for better performance.
Rigorous labs demand concrete numbers. Most batches of 3-Bromo-6-Methoxypyridazine arrive as a white to pale-beige solid, stable under ordinary lab conditions, and with a molecular weight clocking in at 203.01 g/mol. The melting point sits in a range that’s easy to handle with common lab equipment. Oddly, in my early days I thought the exact melting point would matter less, but consistency in crystallization speaks volumes about batch-to-batch purity. Besides, any irregularity in the melting range stands out fast and signals a closer inspection—nobody wants to waste time on reactions plagued by inconsistency.
Handling feels straightforward since it isn't particularly hygroscopic or prone to rapid degradation. We all aim to minimize cleanup and maximize yield—so a compound stable in open air always claims a regular spot on my bench. NMR and LCMS verification never failed me with this material; clear signals confirm its structure and reinforce confidence. In teams focused on medicinal chemistry or agricultural research, this kind of predictability helps keep projects moving.
The pharmaceuticals sector never stands still. Each year, new lead series emerge to address evolving bacterial resistance or optimize ADME (absorption, distribution, metabolism, and excretion) of candidates. Pyridazine cores turned up in antiviral, anti-tumor, and anti-inflammatory drugs, always bringing unique interactions with their biological targets. What stands out to me in 3-Bromo-6-Methoxypyridazine is its value as a precursor.
Synthetic chemists reach for it as a reliable starting block in multi-step syntheses. Whether adding complexity through palladium-catalyzed reactions or swapping in new heterocycles, this compound’s structure gives flexibility. A colleague once rebuilt a kinase inhibitor scaffold by doing a bromo-to-amino transformation at the 3-position; starting with 3-Bromo-6-Methoxypyridazine gave higher selectivity and cleaner conversions than other halogenated pyridazines. Moments like this highlight why structure matters so much to a practicing chemist.
Even small tweaks—moving from a methoxy to a methyl group, or placing the bromo elsewhere—show a different reactivity profile. Using the right isomer saves on purification and waste, not to mention cost. With drug discovery under pressure to deliver safe compounds faster, having reliable intermediates like this one really affects the bottom line.
Farmers and agronomists rarely see the chemistry that shapes the next generation of fungicides and herbicides, but a lot of that innovation hinges on molecules like 3-Bromo-6-Methoxypyridazine. Pyridazine derivatives repeatedly show up when seeking better selectivity or lower toxicity—to bees, mammals, and the environment. Making a safer or more potent agent usually starts with exploring how different functional groups perform. Even a single bromo group in the right spot opens doors to whole classes of active compounds.
A few years ago, I worked on optimizing a seed treatment, and our team went through a battery of pyridazine analogues. Having a consistent, pure source made it easy to compare actives and work out structure-activity relationships. Colleagues in specialty chemicals tell similar stories—sometimes it takes months to narrow down which core scaffold offers both ease of modification and the right baseline activity. The process may be invisible to most consumers, but it’s the backbone of every major advance in crop protection.
Within the landscape of pyridazine derivatives, small structural tweaks drive big differences in how reactions proceed and how final compounds behave. Compare this molecule to other bromo-pyridazines or alternatives like 3,6-dichloropyridazine. The methoxy group doesn’t just serve as another functional handle but can enhance solubility and reduce by-product formation, giving more control in tricky coupling steps.
Sometimes, switching away from a chlorine or a nitro group to a bromo/methoxy combination lowers the barrier for certain nucleophilic substitutions or helps in cross-coupling conditions where milder reagents give fewer side products. Years spent troubleshooting scale-ups taught me that unreliable reactions eat into profits and patience. A compound that balances reactivity and stability shapes everything from reaction timelines to filtration ease.
The experience of handling closely related isomers stands out as well. Reactions with 3-Bromo-5-Methoxypyridazine or their methyl-substituted cousins generate different outcomes—yield, product purity, and even byproducts can shift. With 3-Bromo-6-Methoxypyridazine, runs generally go off without a hitch, a pattern noticed by both process chemistry teams and synthetic students. While saving time might sound cliché, in laboratories dealing with hundreds of parallel syntheses, small advantages spell the difference between reaching a milestone this quarter or falling behind.
In an ideal world, everyone has a robust, local source for key reagents. Reality brings backorders, sudden purity drops, and those frustrating delays when a project’s momentum screeches to a halt. A supply chain that delivers high-purity material—with solid documentation—makes planning possible. During the pandemic years, raw material shortages pushed chemists to re-examine their reagents. Many of us rediscovered the value of having more than one trusted supplier, but also saw how often certain compounds simply outperformed others during shortages. 3-Bromo-6-Methoxypyridazine became a steady player, especially when alternative halides were harder to come by or showed higher impurity loads.
After batch arrival, easy-to-read analytical data remains crucial. HPLC, NMR, and mass spec traces included with shipments save days of in-house checks and help identify any outliers before they affect downstream reactions. Working in regulated environments, this traceability isn’t an optional perk; it’s a necessity. Solid documentation ties into both research efficiency and compliance for those in regulated markets, a lesson that grows more relevant as quality standards get stricter globally.
Modern chemistry means keeping a close eye on environmental impact. Regulations push industry to use less hazardous reagents, cut hazardous waste, and aim for processes that protect workers and the planet. 3-Bromo-6-Methoxypyridazine lands in a manageable toxicity range compared to other halogenated heterocycles. It isn’t volatile under room conditions, giving a margin of safety during handling. Not everything in the lab smells pleasant or brings peace of mind, but straightforward precautions—good ventilation, gloves, and eye protection—are usually plenty.
Everyone remembers a spill or a reaction gone awry, but in my experience, this compound doesn’t present real surprises with decomposition or fumes under routine conditions. Compared to older aromatic bromides or certain chlorinated intermediates, the safety profile is actually a step up. Proper labeling and storage round out the management, so teaching new lab members about its hazards takes minutes, not hours.
Research teams frequently depend on a handful of intermediates to keep pipelines moving, which brings frustrating bottlenecks when demand outpaces supply. Several years ago, an uptick in demand for pyridazine derivatives meant certain suppliers couldn’t keep up, putting deadlines in jeopardy. Looking long-term, a more regionalized supply network and encouraging multiple manufacturers to invest in robust, low-waste syntheses seem like practical steps to guard against disruptions. Efficient production methods—such as using more atom-economical routes and responsible bromine sourcing—would make this compound both cheaper and more sustainable.
Chemists also share insights, publishing improved synthetic routes to help colleagues dodge problematic steps and hazardous reagents. Collaboration across academia and industry on best practices helps everyone. If manufacturers openly share not only product specs but also storage recommendations and impurity profiles, users get transparency that supports smarter decisions. Progress doesn’t only show up in higher yields or easier handling, but in conversations in break rooms about what works, what doesn’t, and why.
The last few years have brought new expectations around transparency and data-sharing in chemical sourcing. Increasingly, users ask for sustainability metrics, batch-to-batch performance data, and clear information about storage and reactivity. From my perspective, the best suppliers offer not only high-purity products but also lay out trace metals content, packaging materials, and even details about transport emissions. This ripple of openness nudges everyone toward safer, better science—not just faster pipelines.
In practice, traceability from procurement to finished product creates fewer headaches and surprises. Sometimes a tricky impurity can derail an entire synthetic sequence, and the cost of troubleshooting rises steeply. Straightforward documentation and honest communication about reactivity quirks set up customers for success, not frustration. Trust follows transparency, and word-of-mouth travels quickly in the close-knit research community. As more organizations put environmental, safety, and reproducibility data front and center, the industry benefits as a whole.
While product brochures can make everything look easy, real-world results matter more. Experienced chemists take notes on every variable that makes projects run smoothly. One colleague shared how a switch from 3,6-dichloropyridazine to 3-Bromo-6-Methoxypyridazine lowered their failure rate in key cross-coupling steps, reducing troubleshooting from days to hours. Another team developing new herbicide analogues found improved yield consistency by using the methoxy-containing scaffold as their starting block.
Sometimes differences seem small. Less fouling on glassware, smoother filtration, a cleaner TLC plate. But these improvements add up, freeing time for more creative problem-solving. Over the past decade, I’ve watched teams move more quickly from initial screens to advanced lead compounds, simply because they picked robust building blocks. In corporate R&D, speed translates to budgets, competitiveness, and researcher morale. Nobody wins when reactions stall because of flaky materials.
Broadening access to high-quality specialty chemicals takes more than just increasing production. Sharing best practices in handling—such as rotating stock to avoid degradation, maintaining dry storage, and regularly running quality checks—helps even smaller labs avoid hiccups. By pooling knowledge through conferences, publications, and open online forums, the whole research community gets stronger. Suppliers who listen to user feedback incorporate real-world experiences into future batches, weeding out problems before they hit the bench.
Scaling up remains a unique challenge. As research moves from milligrams to kilograms, reaction quirks sometimes multiply. Open sharing of scale-up pitfalls—like solubility quirks, heat management, or separation headaches—can save months of effort. In the broader world of green chemistry, incremental improvements like solvent swaps or alternative catalysts steer synthesis toward safer, less resource-intensive processes. Chemists who pay attention to these factors help reduce the environmental footprint and, in turn, see fewer regulatory headaches down the road.
It’s tempting to see any specialty chemical as just another option in a thick catalog, but the difference between a good intermediate and a forgettable one lies in the details. 3-Bromo-6-Methoxypyridazine stands out for the flexibility its structure gives, the predictability it brings to synthesis, and the reliability users get in both R&D and industrial settings. It’s shaped countless projects across pharmaceuticals, agrochemicals, and fine chemicals—sometimes as the star, sometimes as the unsung hero that made creative leaps possible.
With every successful synthesis, the underpinning confidence comes from solid, reproducible starting points. This compound, with its balance of practical reactivity and straightforward handling, underlines how thoughtful substitution on a simple scaffold paves the way for innovative science. As discovery and optimization in chemistry become more data-driven and collaborative, the need for transparent sourcing, responsible manufacture, and open dialogue only grows. Products like 3-Bromo-6-Methoxypyridazine will keep playing a pivotal role, not because they promise magic, but because they deliver exactly what experienced hands expect—reliability, quality, and the chance to push science forward.